-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IKwwkfS4p3sQHNBJm8IBHCFKh3mvwZFAYCqCkWY4fN1W46/HgKAWAC6KMuUe3QyK SMhozib9DGQiqI6//0BVBQ== 0000950156-07-000518.txt : 20070820 0000950156-07-000518.hdr.sgml : 20070820 20070820140039 ACCESSION NUMBER: 0000950156-07-000518 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20070815 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070820 DATE AS OF CHANGE: 20070820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGI INC CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 071067395 BUSINESS ADDRESS: STREET 1: WHEAT RD AND LINCOCN AVE STREET 2: P O BOX 687 CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 6096971441 MAIL ADDRESS: STREET 1: WHEAT ROAD AND LINCOCN AVE STREET 2: P O BOX 687 CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 8-K 1 d67992_igi-8k.htm BODY OF FORM 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

____________

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 15, 2007

 

___________________________________________________________

 

IGI, INC.

(Exact Name of Registrant as Specified in Charter)

 

___________________________________________________________

 

Delaware

001-08568

01-0355758

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(I.R.S. Employer
Identification Number)

     

105 Lincoln Avenue
Buena, New Jersey 08310
(Address of Principal Executive Offices) (Zip Code)

 

(856) 697-1441
(Registrant's Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-(c))

<PAGE>

Item 2.02. Results of Operations and Financial Condition

 

      On August 15, 2007, IGI, Inc. (the "Company") issued a press release announcing the Company's earnings for the second quarter ended June 30, 2007. A copy of the press release is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

      99.1    IGI, Inc. Press Release dated August 15, 2007

<PAGE>

SIGNATURES

 

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 

IGI, INC.

   
 

By:

/s/ Carlene Lloyd

   


   

Carlene Lloyd
Vice President of Finance

     

Date:  August 20, 2007

   

<PAGE>

EXHIBIT INDEX

 

Exhibit
Number

 


Description

     

99.1

 

IGI, Inc. Press Release dated August 15, 2007

<PAGE>  

EX-99 2 ex991_67992.htm EXHIBIT 99.1

News From

 

 

Buena, NJ 08310

 

 

Release Date: August 15, 2007

Exhibit 99.1

 

Contact:

Rajiv Mathur

 

President & Chief Executive Officer

 

IGI, Inc.

 

856-697-1441 ext. 211

 

www.askigi.com

 

 

IGI, INC. ANNOUNCES SECOND QUARTER 2007 RESULTS

 

BUENA, NJ August 15, 2007 - IGI, INC. (AMEX: IG) announces business highlights and second quarter 2007 financial results.

 

Highlights:

 

 

*

Quarterly sales revenues hit $1 million dollars for the first time in 12 quarters

 

*

Total revenues increased 34% in the second quarter of 2007 compared to first quarter 2007

 

*

Net losses were reduced by 58% from first quarter to second quarter

 

*

Initiated new product development for launch in 2008, 2009, and 2010

 

*

Research has been completed for a new patent and we have initiated patent application filling

 

*

Negotiating several manufacturing and supply agreements which we are aiming to finalize in third quarter 2007

 

Six months ended June 30, 2007 Financial Results

 

Total revenues increased $523,000, or 37% from $1,398,000 for the six months ended June 30, 2006 to $1,921,000 for the six months ended June 30, 2007. Product sales increased 57% as a result of an increase in sales volume due to the Company's packaging capabilities that began in 2007. Our research and development revenues increased by 77% as a result of an increase in product development services provided our customers. The decline in royalty revenue of 24% was related to a decline in royalties from Johnson & Johnson and Estee Lauder in 2007.

 

Total costs and expenses for the Company increased 18% for the six months ended June 30, 2007 compared to June 30, 2006. The increase in total costs and expenses substantially related to an increase in costs of goods sold from improved product sales offset by a slightly better absorption of fixed costs in 2007. There was also an increase in selling, general and administration expenses relating to stock option expense, salaries, and consulting fees.

 

The total net loss of the Company for the six months ended June 30, 2007 was $582,000, which represents a decrease in net loss of $238,000 compared to the six months ended June 30, 2006. The decrease in net loss relates to the increase in revenues offset by the increase in costs for the period ended June 30, 2007.

 

This report contains forward-looking statements relating to IGI's hopes and expectations for the future. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as "will," "possible," "one time," "provides an opportunity," "continue" and similar expressions are intended to identify forward-looking statements. Such statements involve a number of risks and uncertainties and actual future events and results could differ materially from those indicated by such forward-looking statements due to general economic conditions, and the risk factors detailed in IGI's periodic reports and registration statements filed with the Securities and Exchange Commission.

<PAGE>  

IGI, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share information)

(Unaudited)

 

Three months
ended June 30,

Six months
ended June 30,



2007

2006

2007

2006





Revenues:

    Product sales, net

$          741 

$          490 

$       1,345 

$          856 

    R&D Revenues

191 

133 

268 

163 

    R&D Revenue- related party

20 

20 

    Licensing and royalty income

148 

194 

288 

379 





        Total revenues

1,100 

817 

1,921 

1,398 

Cost and expenses:

    Cost of sales

622 

433 

1,138 

691 

    Selling, general and administrative expenses

596 

442 

1,182 

900 

    Product development and research expenses

114 

271 

225 

561 





Operating loss

(232)

(329)

(624)

(754)

Interest expense (net)

(8)

(28)

(27)

(70)

Other income

64 

64 

24 





Loss from continuing operations

(176)

(357)

(587)

(800)

Gain (loss) from discontinued operations

(11)

(20)





Net loss

$         (171)

$         (368)

$         (582)

$         (820)





Basic and Diluted Loss Per Share

Continued operations net loss per share

$          (.01)

$          (.03)

$          (.04)

$          (.06)

Discontinued operations net income (loss) per share





    Net loss per share

$          (.01)

$          (.03)

$          (.04)

$          (.06)





Weighted Average of Common Stock and Common Stock
  Equivalents Outstanding

    Basic and diluted

14,612,899 

12,781,255 

13,997,904 

12,705,984 

<PAGE>  

IGI, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share information)

 

 

 

June 30, 2007

December 31, 2006*



(unaudited)

ASSETS

Current assets:

    Cash and cash equivalents

$      123 

$      619 

    Restricted cash

50 

50 

    Accounts receivable, less allowance for doubtful accounts

      of $33 in 2007 and $ 34 in 2006

609 

197 

    Accounts receivable- related party

20 

    Licensing and royalty income receivable

102 

91 

    Inventories

474 

485 

    Prepaid expenses and other current assets

103 

45 

    Assets of discontinued operations held for sale

350 



        Total current assets

1,481 

1,837 

Property, plant and equipment, net

2,423 

2,396 

License fee, net

850 

900 

Other assets

10 



        Total assets

$   4,756 

$   5,143 



LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

    Note payable - related party

$      500 

$   1,451 

    Accounts payable

446 

505 

    Accrued expenses

395 

417 

    Deferred income, current

293 

400 

    Liabilities of discontinued operations

118 



        Total current liabilities

1,634 

2,891 

Deferred income

47 

59 



        Total liabilities

1,681 

2,950 



Stockholders' equity:

    Common stock $.01 par value, 50,000,000 shares
      authorized; 16,578,639 and 15,056,516 shares
      issued in 2007 and 2006, respectively



166 



151 

    Additional paid-in capital

27,018 

25,569 

    Accumulated deficit

(22,714)

(22,132)

    Less treasury stock, 1,965,740 shares at cost

(1,395)

(1,395)



        Total stockholders' equity

3,075 

2,193 



        Total liabilities and stockholders' equity

$   4,756 

$   5,143 



<PAGE>  

GRAPHIC 3 igi-logo.gif begin 644 igi-logo.gif M1TE&.#EAD`!,`/<``/______S/__F?__9O__,___`/_,___,S/_,F?_,9O_, M,__,`/^9__^9S/^9F?^99O^9,_^9`/]F__]FS/]FF?]F9O]F,_]F`/\S__\S MS/\SF?\S9O\S,_\S`/\`__\`S/\`F?\`9O\`,_\``,S__\S_S,S_F6*3HL"'"A0L?%BQH?D.(IS--(HT-U"E,Y\'K).K=H2`%%Y;X<1@RRY;C3MY,D2-[PK=S-' MT*"3D>!,NR-LN'%'BST<-^X_].IANH].=PBW]?X1&P<>&WH7_G.UZ\?+YSA.N/R_2[ M4];,)7.;9=K-)Y9MW2%'7FK"@119@=\Y)AEX\"5XGX%`-6?A@GRQMY]^GF!8 MD'X0TB=@@@2*>.")MW$H5GT.)M.?@5%-.-EQH%VHHD4:YNBB59[T-EY'.SKQ MU'8L)ECBCA4AV&)Y%`4G6%S"/$?DCIB]AV)H4#+98W(_WF2:8(A5Q>1RW+5X MYDU.*MGE15-6*9B5(:ZI97QAVAG1EYGE:9&$':T55YUZ%I:FDH4VF61L;P*0 MGIQ51D9HHBMNJ:.>?')IU7_MD3DHI7T=ZAVH$;7)*)"!5BF>5Z16BF>C(F;_ M>BE%?RE%)JNM6B6J@KF:JN";[4%ZZZ2YKH0CF+!B**N?$QTP7:!DTEELAHOR MVJJO!'89')6K?CJM3R^ZL$K'';;0@JFMLA3Z. M.U^Y5CU+KY6HV3O1KNV2BBV\E*5*;UP!"UPJOLBVRB]024$+&,,.=_;NDGH> MS.Q$.3W7;3(-.QRNIJ1.'!1BZ)9L4V-YQ2RS)]791+!FF^D[D<>-8K=PNIMV M);1'9H(+L;BH8W>S+%82@=0&,]7_3&VBI1]3%"B54R;V7=7_1E;SBQM__][6-O<]'^1NL[GQN"SW1K)UB`?F;5^- MQ\W7WZ&O-#E0VV(75]&(=_ MWS2[52I`&QKS?+%(=/BLH^??"C7Q%2A<4>V>? M;8A\Y?K--EGE0_;NVN^?B]Z]QO>^PQ1.7V\9$BG>UYM780AVY6L0;HPWGQJQ MA2]O"4U'7/8U"4[P>P&$W!/TD(<2FC`/GOG@749R0A,69@7X(QGZXB64NG5D M;V$C80OUT!L5QD6'+9RA5?\"H(*N67!H0LN9='0BDJULA#5DXB#ED#@TW$$/ MO&+7GQ?%O50L9X4A20J``X8U\A&+BZM:T7,V$I` M=LPCDPY0`CX>8'YZ#*3?`E`"`Y3@?8(4)`Q)P4@]!"``?TRD)"&:2=$:A*+1/QF"=SFSCN6TR*@RR;2M!1`]`@G\:\@#WE$A&#Y#/^-VQIJ#[6T<+ M^=&$QG2.",VHTG`J5**VK:A")4%/_?C3Q_WSGT@U:D:-*K\B+E2B,&TJ9TKZ HU$+VL:5<+2D`^/A2L';UHEI=#EA?&M:RDG6B445K6@O5U7\Z+"``.S\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----